Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences

Company Overview - Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company focused on pioneering medicines that transform patients' lives [3] - The company utilizes its Genome5000™ program to study nearly 5,000 genes, identifying over 100 protein targets with significant therapeutic potential across various diseases [3] - Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in areas such as heart failure, neuropathic pain, obesity, cardiology, and diabetes [3] Upcoming Events - Company management will participate in a fireside chat at Citi's Biopharma Back to School Conference on September 3 at 1:45 p.m. ET [1] - The company will also present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8 at 3:00 p.m. ET [1] - Live events and replays of the presentations will be accessible via the company's Events page on its website [2]